Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine C Siska

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Molecular Pharmaceutics|August 22, 2014
Relationship between native-state solubility and non-native aggregation of recombinant human granulocyte colony stimulating factor: practical implications for protein therapeutic developmentDouglas D Banks, Jun Zhang, Christine C Siska
Analytical Biochemistry|March 9, 2004
High-performance liquid chromatography-based protease detection at the picogram levelEdward J Bures, Christine C Siska, Andrei A Raibekas
Biophysical Journal|May 20, 2009
Kinetic folding mechanism of erythropoietinDouglas D Banks, Joanna L Scavezze, Christine C Siska
Analytical Chemistry|July 28, 2009
Detection and quantitation of IgG 1 hinge aspartate isomerization: a rapid degradation in stressed stability studiesDavid M Hambly, Douglas D Banks, Joanna L Scavezze, et al.
Biochemistry|July 20, 2005
Anion binding and controlled aggregation of human interleukin-1 receptor antagonistAndrei A Raibekas, Edward J Bures, Christine C Siska, et al.
Journal of Pharmaceutical Sciences|April 24, 2009
The effect of sucrose hydrolysis on the stability of protein therapeutics during accelerated formulation studiesDouglas D Banks, David M Hambly, Joanna L Scavezze, et al.
Journal of Pharmaceutical Sciences|September 9, 2014
Free fatty acid particles in protein formulations, part 2: contribution of polysorbate raw materialChristine C Siska, Christopher J Pierini, Hollis R Lau, et al.
Journal of Pharmaceutical Sciences|June 1, 2012
Native-state solubility and transfer free energy as predictive tools for selecting excipients to include in protein formulation development studiesDouglas D Banks, Ramil F Latypov, Randal R Ketchem, et al.
Journal of Pharmaceutical Sciences|September 2, 2014
Free fatty acid particles in protein formulations, part 1: microspectroscopic identificationXiaolin Cao, R Matthew Fesinmeyer, Christopher J Pierini, et al.
Antibody Therapeutics|October 9, 2024
AI-based antibody discovery platform identifies novel, diverse, and pharmacologically active therapeutic antibodies against multiple SARS-CoV-2 strainsCristina Moldovan Loomis, Thomas Lahlali, Danielle Van Citters, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Molecular Pharmaceutics|August 22, 2014
Relationship between native-state solubility and non-native aggregation of recombinant human granulocyte colony stimulating factor: practical implications for protein therapeutic developmentDouglas D Banks, Jun Zhang, Christine C Siska
Analytical Biochemistry|March 9, 2004
High-performance liquid chromatography-based protease detection at the picogram levelEdward J Bures, Christine C Siska, Andrei A Raibekas
Biophysical Journal|May 20, 2009
Kinetic folding mechanism of erythropoietinDouglas D Banks, Joanna L Scavezze, Christine C Siska
Analytical Chemistry|July 28, 2009
Detection and quantitation of IgG 1 hinge aspartate isomerization: a rapid degradation in stressed stability studiesDavid M Hambly, Douglas D Banks, Joanna L Scavezze, et al.
Biochemistry|July 20, 2005
Anion binding and controlled aggregation of human interleukin-1 receptor antagonistAndrei A Raibekas, Edward J Bures, Christine C Siska, et al.
Journal of Pharmaceutical Sciences|April 24, 2009
The effect of sucrose hydrolysis on the stability of protein therapeutics during accelerated formulation studiesDouglas D Banks, David M Hambly, Joanna L Scavezze, et al.
Journal of Pharmaceutical Sciences|September 9, 2014
Free fatty acid particles in protein formulations, part 2: contribution of polysorbate raw materialChristine C Siska, Christopher J Pierini, Hollis R Lau, et al.
Journal of Pharmaceutical Sciences|June 1, 2012
Native-state solubility and transfer free energy as predictive tools for selecting excipients to include in protein formulation development studiesDouglas D Banks, Ramil F Latypov, Randal R Ketchem, et al.
Journal of Pharmaceutical Sciences|September 2, 2014
Free fatty acid particles in protein formulations, part 1: microspectroscopic identificationXiaolin Cao, R Matthew Fesinmeyer, Christopher J Pierini, et al.
Antibody Therapeutics|October 9, 2024
AI-based antibody discovery platform identifies novel, diverse, and pharmacologically active therapeutic antibodies against multiple SARS-CoV-2 strainsCristina Moldovan Loomis, Thomas Lahlali, Danielle Van Citters, et al.
Pageof 1